vTv Therapeutics Inc.
VTVT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641489
No open-market purchases or sales by vTv Therapeutics Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $60.5M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in vTv Therapeutics Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- 0 vs. Q1 2024
- Shares held
- 348.1K
- +14.5K (+4.3%) vs. Q1 2024
- Total value
- $6.15M
- −$1.70M (−21.7%) vs. Q1 2024
- New holders
- 5
- 3 more added
- Sold out
- 5
- 1 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $60.5M |
| Q1 2026 | 35 | $59.0M |
| Q4 2025 | 27 | $51.3M |
| Q3 2025 | 23 | $23.1M |
| Q2 2025 | 21 | $8.74M |
| Q1 2025 | 21 | $9.90M |
| Q4 2024 | 17 | $7.57M |
| Q3 2024 | 20 | $7.34M |
| Q2 2024 | 19 | $6.15M |
| Q1 2024 | 19 | $7.85M |
| Q4 2023 | 14 | $788.7K |
| Q3 2023 | 25 | $1.65M |
| Q2 2023 | 20 | $2.60M |
| Q1 2023 | 24 | $2.88M |
| Q4 2022 | 30 | $2.47M |
| Q3 2022 | 27 | $3.38M |
| Q2 2022 | 23 | $2.75M |
| Q1 2022 | 25 | $3.76M |
| Q4 2021 | 29 | $6.49M |
| Q3 2021 | 31 | $5.17M |
| Q2 2021 | 42 | $9.89M |
| Q1 2021 | 48 | $13.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding vTv Therapeutics Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 206,784 | $3.65M | 0.76% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 97,314 | $1.72M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 24,558 | $433.7K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 12,256 | $216.4K | 0.00% | +12,256 | New |
| UBS Group AG | 4,180 | $73.8K | 0.00% | +2,723+186.9% | Added |
| BlackRock Inc. | 1,097 | $19.4K | 0.00% | +18+1.7% | Added |
| Morgan Stanley | 840 | $14.8K | 0.00% | 00.0% | Unchanged |
| Planning Capital Management Corp | 625 | $11.0K | 0.01% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 170 | $3.00K | 0.00% | +20+13.3% | Added |
| Strengthening Families & Communities, LLC | 173 | $3.00K | 0.00% | +173 | New |
| Activest Wealth Management | 50 | $883 | 0.00% | +50 | New |
| Parallel Advisors, LLC | 38 | $671 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 19 | $277 | 0.00% | 00.0% | Unchanged |
| Sunbelt Securities, Inc. | 15 | $265 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 9 | $159 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 8 | $141 | 0.00% | −68−89.5% | Reduced |
| JPMorgan Chase & Co | 2 | $35 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 1 | $18 | 0.00% | +1 | New |
| Triad Wealth Partners, LLC | 1 | $18 | 0.00% | +1 | New |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −535−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −104−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Central Trust Co | 0 | $0 | 0.00% | −5−100.0% | Sold out |